Vizsgálati helyszín
St. Luke's University Health Network
Bethlehem, Pennsylvania 18015, Egyesült ÁllamokMég nincs intézményhez kötve
- 20futó vizsgálat
- 4lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 24 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis8 vizsgálat
- 2/3. fázis3 vizsgálat
- 1. fázis2 vizsgálat
- 2. fázis1 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Fut, nem toboroz10 vizsgálat
- Toboroz10 vizsgálat
- Lezárult3 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Hoffmann-La Roche4 vizsgálat
- Bristol-Myers Squibb2 vizsgálat
- Medtronic2 vizsgálat
- United Therapeutics2 vizsgálat
- Actuate Therapeutics Inc.1 vizsgálat
- és még 13
Futó vizsgálatok
Toboroz
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
NCT07310420· 1. fázis· TerSera Therapeutics LLC· Forrás
Contact: Maria Hafez, MD
Toboroz
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336· 3. fázis· Eli Lilly and Company· Forrás
Contact: Maria Hafez (principal investigator)
Toboroz
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
NCT07076121· 2/3. fázis· Bristol-Myers Squibb· Forrás
Toboroz
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
NCT06909565· 4. fázis· Duke University· Forrás
Contact: Kyle McFadden
Fut, nem toboroz
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
NCT06619236· 3. fázis· Genmab· Forrás
Toboroz
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT06388421· United Therapeutics· Forrás
Contact: Douglas Corwin, MD
Toboroz
Nectero EAST System Clinical Study
NCT06001918· 2/3. fázis· Nectero Medical, Inc.· Forrás
Contact: Jena Hagerty
Toboroz
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
NCT05489705· Bristol-Myers Squibb· Forrás
Contact: Jamshid Shirani, Site 0043
Toboroz
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888· Temple University· Forrás
Contact: Monica Hosler
Toboroz
Advanced SPinal Innovations With Robotics and Enabling Technology Registry
NCT05071144· Boston Children's Hospital· Forrás
Contact: Dustin Greenhill, MD
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
NCT04586010· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
NCT04575935· 3. fázis· M.D. Anderson Cancer Center· Forrás
Contact: Nicholas Taylor, MD
Fut, nem toboroz
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
NCT04496518· Medtronic· Forrás
Fut, nem toboroz
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
NCT03589339· 1. fázis· Nanobiotix· Forrás
Fut, nem toboroz
9-ING-41 in Patients With Advanced Cancers
NCT03678883· 2. fázis· Actuate Therapeutics Inc.· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT03178552· 2/3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
NCT04024943· Medtronic· Forrás
Fut, nem toboroz
Heart Attack Research Program- Imaging Study
NCT02905357· NYU Langone Health· Forrás
Fut, nem toboroz
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986· 3. fázis· AstraZeneca· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek